NCT07514637 clinical trial report covering Anrikefon, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07514936 clinical trial report covering Chidamide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07514429 clinical trial report covering Regorafenib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600121980 clinical trial report covering Apatinib Mesylate, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07514455 clinical trial report covering Regorafenib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07514533 clinical trial report covering Pucotenlimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07514169 clinical trial report covering Polatuzumab Vedotin-Piiq, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07515014 clinical trial report covering E-6742, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07514793 clinical trial report covering Iparomlimab/Tuvonralimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07514832 clinical trial report covering Venetoclax, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07515625 clinical trial report covering Sintilimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07515820 clinical trial report covering SHR-3821, Phase 2, endpoints, sponsor, geography, readout timing and development white space.